{"id":"https://openalex.org/W1992959393","doi":"https://doi.org/10.1089/jir.2012.0148","title":"Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b","display_name":"Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b","publication_year":2013,"publication_date":"2013-08-20","ids":{"openalex":"https://openalex.org/W1992959393","doi":"https://doi.org/10.1089/jir.2012.0148","mag":"1992959393","pmid":"https://pubmed.ncbi.nlm.nih.gov/23962003","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3868373"},"language":"en","primary_location":{"id":"doi:10.1089/jir.2012.0148","doi":"https://doi.org/10.1089/jir.2012.0148","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.2012.0148","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3868373/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025620998","display_name":"Ji I. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146987","display_name":"Bolder Biotechnology, Inc.","ror":"https://ror.org/050qew682","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ji I. Lee","raw_affiliation_strings":["Bolder BioTechnology, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bolder BioTechnology, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210146987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058527628","display_name":"Stephen P. Eisenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146987","display_name":"Bolder Biotechnology, Inc.","ror":"https://ror.org/050qew682","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen P. Eisenberg","raw_affiliation_strings":["Bolder BioTechnology, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bolder BioTechnology, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210146987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005741526","display_name":"Mary S. Rosendahl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146987","display_name":"Bolder Biotechnology, Inc.","ror":"https://ror.org/050qew682","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary S. Rosendahl","raw_affiliation_strings":["Bolder BioTechnology, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bolder BioTechnology, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210146987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038275537","display_name":"Elizabeth A. Chlipala","orcid":"https://orcid.org/0000-0002-2194-7645","observed_orcids":["https://orcid.org/0000-0002-2194-7645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth A. Chlipala","raw_affiliation_strings":["Premier Laboratory, LLC, Longmont, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Premier Laboratory, LLC, Longmont, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004659620","display_name":"Jacquelyn D. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146987","display_name":"Bolder Biotechnology, Inc.","ror":"https://ror.org/050qew682","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacquelyn D. Brown","raw_affiliation_strings":["Bolder BioTechnology, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bolder BioTechnology, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210146987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043026422","display_name":"Daniel H. Doherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146987","display_name":"Bolder Biotechnology, Inc.","ror":"https://ror.org/050qew682","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel H. Doherty","raw_affiliation_strings":["Bolder BioTechnology, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bolder BioTechnology, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210146987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113630866","display_name":"George N. Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146987","display_name":"Bolder Biotechnology, Inc.","ror":"https://ror.org/050qew682","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146987"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George N. Cox","raw_affiliation_strings":["Bolder BioTechnology, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bolder BioTechnology, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210146987"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113630866"],"corresponding_institution_ids":["https://openalex.org/I4210146987"],"apc_list":null,"apc_paid":null,"fwci":0.6539,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.64380613,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"33","issue":"12","first_page":"769","last_page":"777"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.21130000054836273,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.21130000054836273,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1624000072479248,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.12370000034570694,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-beta-1b","display_name":"interferon beta-1b","score":0.9350000023841858},{"id":"https://openalex.org/keywords/site-specific-pegylation","display_name":"site-specific PEGylation","score":0.8849999904632568},{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.8109999895095825},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7379999756813049},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.6830000281333923},{"id":"https://openalex.org/keywords/protein-bioactivity","display_name":"protein bioactivity","score":0.5659999847412109},{"id":"https://openalex.org/keywords/n-terminal-modification","display_name":"N-terminal modification","score":0.6700000166893005},{"id":"https://openalex.org/keywords/lysine-modification","display_name":"lysine modification","score":0.7580000162124634},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8669999837875366},{"id":"https://openalex.org/keywords/protein-half-life","display_name":"protein half-life","score":0.40400001406669617}],"concepts":[{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.9685301184654236},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.699129045009613},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6801209449768066},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6776663064956665},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.6464497447013855},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.5987840294837952},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5628134608268738},{"id":"https://openalex.org/C2779201268","wikidata":"https://www.wikidata.org/wiki/Q186474","display_name":"Cysteine","level":3,"score":0.542503297328949},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5272083878517151},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5127533674240112},{"id":"https://openalex.org/C2776016237","wikidata":"https://www.wikidata.org/wiki/Q178430","display_name":"Lysine","level":3,"score":0.4988687038421631},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4617929458618164},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.36176741123199463},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1816592514514923},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.17733094096183777},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15101897716522217},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068576","descriptor_name":"Interferon beta-1b","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/jir.2012.0148","doi":"https://doi.org/10.1089/jir.2012.0148","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.2012.0148","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},{"id":"pmid:23962003","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23962003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3868373","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3868373/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Interferon Cytokine Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3868373","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3868373/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Interferon Cytokine Res","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G699941394","display_name":"LONG-ACTING BETA INTERFERON FOR MULTIPLE SCLEROSIS","funder_award_id":"R43NS040205","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G802152507","display_name":"Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing","funder_award_id":"R44NS040205","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W131526502","https://openalex.org/W1492171676","https://openalex.org/W1529853088","https://openalex.org/W1733895450","https://openalex.org/W1769031535","https://openalex.org/W1775469721","https://openalex.org/W1965918908","https://openalex.org/W1977404966","https://openalex.org/W1984327456","https://openalex.org/W1984583580","https://openalex.org/W1987119060","https://openalex.org/W1992295523","https://openalex.org/W1997824576","https://openalex.org/W1998668416","https://openalex.org/W1999811623","https://openalex.org/W2007844082","https://openalex.org/W2024368730","https://openalex.org/W2039871617","https://openalex.org/W2040587518","https://openalex.org/W2043136359","https://openalex.org/W2046434858","https://openalex.org/W2062064156","https://openalex.org/W2078160959","https://openalex.org/W2084718555","https://openalex.org/W2091127292","https://openalex.org/W2093467319","https://openalex.org/W2095199800","https://openalex.org/W2095304434","https://openalex.org/W2100513413","https://openalex.org/W2121003325","https://openalex.org/W2122290258","https://openalex.org/W2144637577","https://openalex.org/W2233606434","https://openalex.org/W2314329153","https://openalex.org/W2332599890","https://openalex.org/W2332630894","https://openalex.org/W2418075308","https://openalex.org/W2741677950","https://openalex.org/W3022669110","https://openalex.org/W3025553878","https://openalex.org/W4406066367"],"related_works":["https://openalex.org/W2043136359","https://openalex.org/W1897820813","https://openalex.org/W7117661573","https://openalex.org/W2335479685","https://openalex.org/W2039871617","https://openalex.org/W1929461104","https://openalex.org/W4388541074","https://openalex.org/W2321694191","https://openalex.org/W4406066367","https://openalex.org/W2990926492"],"abstract_inverted_index":{"Interferon":[0],"beta":[1],"(IFN-\u03b2)":[2],"is":[3],"widely":[4],"used":[5],"to":[6,73,117,124,136,156,163,169,185],"ameliorate":[7],"disease":[8],"progression":[9],"in":[10,20,49,57,64,89,122,142,159,202],"patients":[11],"with":[12,32,59,104],"Multiple":[13],"Sclerosis.":[14],"IFN-\u03b2":[15,31,58,84,137,186,193],"has":[16],"a":[17,115,176,198],"short":[18],"half-life":[19],"humans,":[21],"necessitating":[22],"frequent":[23],"administration":[24],"for":[25],"optimum":[26],"effectiveness.":[27],"Covalent":[28],"modification":[29,53,74,97],"of":[30,40,54,67,75,98,101,114,141,150,197],"polyethylene":[33],"glycol":[34],"(PEG)":[35],"improves":[36],"the":[37,41,47,63,68,99,102,151],"pharmacokinetic":[38,182],"properties":[39,183],"protein,":[42],"but":[43],"can":[44,133],"adversely":[45],"affect":[46],"protein's":[48],"vitro":[50,65,90,143,160],"bioactivity.":[51,144],"Random":[52],"lysine":[55,76],"residues":[56,77],"amine-reactive":[60],"PEGs":[61],"decreased":[62],"bioactivity":[66,91],"protein":[69,103,179],"50-fold,":[70],"presumably":[71],"due":[72],"near":[78],"critical":[79],"receptor":[80],"binding":[81],"sites.":[82],"PEGylated":[83],"proteins":[85,167],"that":[86,148,175],"retained":[87],"high":[88],"could":[92],"be":[93,134],"obtained":[94],"by":[95],"selective":[96],"N-terminus":[100],"PEG.":[105],"Here":[106],"we":[107,146],"use":[108],"site-specific":[109],"PEGylation":[110],"technology":[111],"(targeted":[112],"attachment":[113],"cysteine-reactive-PEG":[116],"an":[118],"engineered":[119],"cysteine":[120],"residue":[121],"IFN-\u03b2)":[123],"identify":[125],"several":[126],"additional":[127],"amino":[128],"acid":[129],"positions":[130],"where":[131],"PEG":[132],"attached":[135],"without":[138],"appreciable":[139],"loss":[140],"Unexpectedly,":[145],"found":[147],"most":[149],"PEG-IFN-\u03b2":[152,178],"analogs":[153],"showed":[154,174],"11-":[155],"78-fold":[157],"improved":[158,181],"bioactivities":[161],"relative":[162],"their":[164],"unPEGylated":[165],"parent":[166],"and":[168,187],"IFN-\u03b2-1b.":[170],"In":[171],"vivo":[172],"studies":[173],"lead":[177],"had":[180],"compared":[184],"was":[188],"significantly":[189],"more":[190],"effective":[191],"than":[192],"at":[194],"inhibiting":[195],"growth":[196],"human":[199],"tumor":[200],"xenograft":[201],"athymic":[203],"mice.":[204]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}